23:42

India's First Sponsored MRCPCH/MRCOG Training Program (Recorded Version)

18:04

Role of Device Therapy in HF Dr. Ulhas Pandurangi

09:26

Session 5: Intervention- Discussion

14:10

Role of LVAD in HF Dr. Viveka Kumar

12:50

Role of Beta Blockers in HF by Dr Sandeep Bansal

14:07

Role of High Risk CABG in HF by Dr. K. R. Balakrishnan

12:46

Cardiac Transplant in India Dr. A.G.K.Ghokale

02:06

Closing Remark by Dr P C Monaria and Dr G N Mahapatra

03:30

Session 4: Medical Management Discussion

14:26

Role of MRA in HF Dr. Satyanarayan Routray

15:16

Role of Vericiguat in HF Dr. Prakash Hazra

16:50

Role of SGLT2 Inhibitors in HF Dr. G.S. Wander

18:28

Role of CMR and T1 Mapping in HF – Gold Standard? by Dr. Priya Jagia

20:59

Session 3: Imaging

15:53

Biomarkers in HF – What’S New? Dr. Darshan Jhalla

16:23

Role of 3D Echo and GLS in HF Dr. Satish Govind

15:07

Importance of Discharge Check List & HF Management in HF Clinic Dr. J.J. Dalal

16:18

Role of MIBI Scan in HF Dr. E. Prabhu

16:16

Role of CTA in HF – Overhyped or Mandatory? Dr. Johann Christopher

19:07

Role of PET CT in HF Dr. G.N. Mahapatra

04:07

Session 2 Discussion: Clinical Chairperson: Dr. H.K. Chopra , Dr. P.C Manoria, Dr. Viveka Kumar

19:04

Heart Failure: A 360 Panoramic View by Dr P C Monaria

19:05

Risk Stratification in HFREF– ESC & ACC Guidelines Dr. C.K. Ponde

05:04

Heart Failure: A 360 Panoramic View- Discussion

09:09

NAPCON 2021 Teaser

12:25

Promise of ARNI in HFrEF (A Case based presentation) by Dr C K Ponde

13:10

Cardiotransplant in India - How good are the results? by Dr Anvay Mulay

02:30

Closing Remark by Dr G.N. Mahapatra and Dr P.C.Manoria

11:47

Role of Intervention in Heart Failure Management by Dr Praveen Chandra

16:39

Changing Scenario in Treatment of HF by Dr Ashwin B Mehta

12:02

What is new in Echocardiography for HF evaluation in HFpEF & HFrEF by Dr Navin C Nanda

20:15

Running the race against HF:The progress made so far by Dr P C Manoria

25:07

SESSION-IV (INTERVENTION AS PERMANENT SOLUTION) Discussion

15:37

SESSION-III(MEDICAL MANAGEMENT –SHEET ANCHOR) : Discussion

13:24

SESSION- II (IMAGING PLAYS A VITAL ROLE) : Discussion 3

17:31

SESSION-I (CLINICAL) Discussion 2

23:37

KEYNOTE ADDRESSES ON HEART FAILURE- NEW FRONTIERS - Discussion : Moderator : Dr G N Mahapatra

12:34

Role of CMR & T1 mapping in CHF by Elizabeth Joseph

09:11

Role of Beta-blockersin CHF by Dr G R Kane

16:12

Clinico-echo, SGLT2i Navigationin HFpEF where are we today? by Dr H K Chopra 720p

18:17

Role of PET-CT in CHF by Dr G N Mahapatra

17:30

Management of HFrEF patients with CKD by Dr Hemant Mehta

16:03

Summary Lecture (Current HF treatment recommendations/Update on guidelines) by Dr Jamshed J Dalal

11:36

Role of CABG in CHF by Dr K R Balakrishnan

12:02

What is new in Echocardiography for HF evaluation in HFpEF & HFrEF by Dr Navin C Nanda

20:15

Running the race against HF:The progress made so far by Dr P C Manoria

18:22

SGLTi2 in HFrEF(A Case based presentation) by Dr Praful Kerkar

13:30

Cardio ACC-2021 Consensus- Impacting treatment choices HFrEF by Dr Prakash Sanzgiri

11:47

Role of Interventions in Heart Failure Management by Dr Praveen Chandra

12:33

Role of GLS in CHF by Dr Rakesh Gupta

13:22

Role of Statins in HF by Dr Raman Puri

13:08

Biomarkers of HFrEF by Dr Roopali Khanna

13:04

When to use in ICCU? by Dr Sadanand Shetty

13:14

Role of device therapy in CHF by Dr Ulhas Pandurangi

10:33

Role of MRA in CHF by Dr Sandeep Bansal

16:45

Role of MIBI scan in CHF by Dr Sanjay Gambhir

15:58

Role of CTA in CHF by Dr Sanjaya Vishwamitra

09:13

HFpEF Future Discussion

09:31

Interventions in Heart Failure Discussion 5

03:29

Medical Management ( Pharmacology & Trials) Discussion